Duchenne's Muscular Dystrophy (DMD) Completed Phase 1 Trials for L-Arginine (DB00125)

Also known as: Duchenne's Muscular Dystrophy / Duchenne Muscular Dystrophy (DMD) / Duchenne Muscular Dystrophy / Muscular Dystrophy, Duchenne / Muscular dystrophy

IndicationStatusPhase
DBCOND0066749 (Duchenne's Muscular Dystrophy (DMD))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01388764Safety, Tolerability and Effects of L-Arginine in Boys With Dystrophinopathy on Corticosteroids
NCT02516085Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and MetforminTreatment